|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 800 I STREET, NW |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3173-12
|
||||||||
|
6. House ID# 333530000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Donald Hoppert |
Date | 7/20/2020 10:13:51 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Support increased funding for the Centers for Disease Control and Prevention.
Support increased funding for the Health Resources and Services Administration.
Support adequate funding for a supplemental appropriations bill for the government's COVID-19 public health emergency response.
Support of a total of $50 million in FY 2021 funding for CDC and NIH to conduct public health research into firearm morbidity and mortality prevention.
Support increased FY 2021 funding for CDCs Public Health Emergency Preparedness Cooperative Agreement and ASPRs Hospital Preparedness Program.
Support of a increased funding for the Surveillance for Emerging Threats to Mothers and Babies program in FY 2021.
Support for a $4.5 billion long-term and sustained annual investment in public health infrastructure in legislation to speed the response to the COVID-19 pandemic and to strengthen the public health infrastructure in the long-term.
Support funding for a loan repayment program for public health professionals who agree to serve two years in a local, state, or tribal health department.
Support increased funding in FY 2021 for the Agency for Health Care Research and Quality.
Support increased funding for CDC's National Center for Environmental Health.
Support increased funding for CDC's Climate and Health Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Urge Congress to ensure that any legislation to address climate change maintain Clean Air Act authority to regulate greenhouse gases.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Oppose S. 311, the Born-Alive Abortion Survivors Protection Act.
Oppose Pain-Capable Unborn Child Protection Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Support of a total of $50 million in FY 2021 funding for CDC and NIH to conduct public health research into firearm morbidity and mortality prevention.
Support for the Gun Violence Prevention and Community Safety Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Support efforts to protect the health of older adults during the COVID-19 pandemic.
Support increasing federal Medicaid matching funds and direct aid to states during the COVID-19 pandemic.
Support reopening the Affordable Care Acts federal exchanges in legislation to respond to the COVID-19 pandemic.
H.R. 6637, the Health Equity and Accountability Act of 2020.
Support H.R. 4334, the Supporting Older Americans Act.
Support funding for nonprofit organizations to be engaged in the COVID-19 response.
Support S.3436, the Border Health Security Act of 2020.adequate funding and support for Support funding for school nutrition programs to combat food insecurity during the COVID-19 pandemic.
Support H.R. 6561, the Improving Social Determinants of Health Act of 2020.
Support increased FY 2021 funding for the National Institute for Occupational Safety and Health.
Support increasing Supplemental Nutrition Assistance Program benefits during the COVID-19 pandemic.
Support inclusion of the Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019, in legislation to respond to the COVID-19 pandemic.
Support increased FY 2021 funding for public health data/IT systems modernization within the Centers for Disease Control and Prevention.
Support the Strengthening the Public Health Workforce Act.
Support including $100 million for the Surveillance for Emerging Threats to Mothers and Babies program in COVID-19 legislative response legislation.
Support increased FY 2021 funding for the Agency for Toxic Substances and Disease Registry.
Support of $10 million for CDC to protect and support breastfeeding during the COVID-19 pandemic.
Support updating the CDC COVID-19 surveillance system to collect data on race, ethnicity, sex, age, primary language, sexual orientation, disability status, gender identity and socioeconomic status.
Support measures in future COVID-19 legislation to increase testing to address the needs of our most vulnerable communities.
Support H.R. 1425, the Patient Protection and Affordable Care Enhancement Act.
Support funding for historically black colleges and universities and other minority-serving institutions to strengthen their allied health professions training programs.
Support the creation of a Health Defense Operations budget designation to increase investments in public health and pandemic preparedness.
Support funding priorities as the U.S. begins to prepare for the allocation, distribution and administration of a new COVID-19 pandemic vaccine.
Support the Ensuring Understanding of COVID-19 to Protect Public Health Act.
Support the Health Enterprise Zones Act of 2020.
Support the Protecting the Health of America's Older Adults During COVID-19 and Beyond Act.
Support the COVID-19 Bias and Anti-Racism Training Act.
Support investing in safety net providers that provide maternal and child health services, STI testing and other essential care during the COVID-19 pandemic.
Support action to alleviate the critical shortage across the nation of ventilators and personal protective equipment resulting from the COVID-19 pandemic.
Support actions to protect the food system and food workers during the COVID-19 pandemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Vice President of the U.S., White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Support of the Connecting Americas Active Transportation System Act.
Support funding for active transportation programs, including the Transportation Alternatives Program, be prioritized in any future economic stimulus legislation.
Support the Motor Vehicle Safety title and other pro-safety provisions in the Moving Forward Act.
Support of the INVEST in America Act, that improves transportation safety and accessibility for people bicycling, walking, rolling, and taking transit.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Support for paid sick and family and medical leave and financial assistance for small businesses as the United States faces a sharp increase in community transmission of COVID-19.
Support for S. 3415/H.R. 6150, the Paid Sick Days for Public Health Emergencies and Personal and Family Care Act.
Support the COVID-19 Every Worker Protection Act of 2020.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
Support passage of H.R. 1603, the Alan Reinstein Ban Asbestos Now Act.
Urge Congress to monitor and exercise oversight regarding EPA implementation of the Frank R. Lautenberg Chemical Safety for the 21st Century Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Support increasing U.S. funding to United Nations accounts and lifting the spending cap imposed on contributions to the UN.
Support fully funding the World Health Organization in fiscal year 2021 and reject the Trump administrations plans to cut U.S. funding to the WHO.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOU
16. Specific lobbying issues
Support the Emergency Rental Assistance and Rental Market Stabilization Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. HOUSE OF REPRESENTATIVES, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Support allowing Deferred Action for Childhood Arrivals recipients to maintain DACA work authorization during the COVID-19 pandemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Support H.R. 7120, the George Floyd Justice in Policing Act of 2020.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Support the COVID-19 Bias and Anti-Racism Training Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |